Alok R. Singh

Alok R. Singh

Interventional Cardiology | Cardiology

3101 W Dr Martin Luther King Jr Blvd
Ste 400
Tampa, FL 33607

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Inverse Design of Photonic Surfaces via High throughput Femtosecond Laser Processing and Tandem Neural Networks.

Inverse Design of Photonic Surfaces via High throughput Femtosecond Laser Processing and Tandem Neural Networks.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 24, 2024

Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodies.

Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodies.

Journal: Scientific reports

Published: April 18, 2022

Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.

Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.

Journal: Med (New York, N.Y.)

Published: April 04, 2022

A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune Cells.

A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune Cells.

Journal: Frontiers in oncology

Published: February 25, 2022

Pacinian Corpuscles in Pancreas: Possible Clinical Implications.

Pacinian Corpuscles in Pancreas: Possible Clinical Implications.

Journal: Pancreas

Published: August 16, 2021

Augmented Antitumor Activity for Novel Dual PI3K/BDR4 Inhibitors, SF2523 and SF1126 in Ewing Sarcoma.

Augmented Antitumor Activity for Novel Dual PI3K/BDR4 Inhibitors, SF2523 and SF1126 in Ewing Sarcoma.

Journal: Journal of pediatric hematology/oncology

Published: April 03, 2020

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.

Journal: Cell discovery

Published: March 31, 2020

Macrophage Syk-PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk-PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression.

Macrophage Syk-PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk-PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression.

Journal: Molecular cancer therapeutics

Published: October 02, 2019

SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer.

SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer.

Journal: Molecular cancer therapeutics

Published: October 22, 2018

Kepler WebView: A Lightweight, Portable Framework for Constructing Real-time Web Interfaces of Scientific Workflows.

Kepler WebView: A Lightweight, Portable Framework for Constructing Real-time Web Interfaces of Scientific Workflows.

Journal: Procedia computer science

Published: February 25, 2017

Dual-activity PI3K-BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis.

Dual-activity PI3K-BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 01, 2017

Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype.

Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype.

Journal: PloS one

Published: January 24, 2017

Showing 1-12 of 23

Last Updated: 09/26/2026